Mammoth Biosciences is a biotechnology company focused on gene editing and diagnostics using CRISPR-based technologies. It develops in vivo gene editing therapeutics and CRISPR-based diagnostic solutions, leveraging its protein discovery and engineering platform to advance genetic medicines. The company highlights its work in delivering permanent cures through precise genome editing and offers technologies that address delivery challenges in vivo. Headquartered in the San Francisco Bay Area, Mammoth Biosciences collaborates with researchers and industry partners to transform patient outcomes.
No recent news for this company.
No recent deals for this company.